When to publish measures of disproportionality derived from spontaneous reporting databases?DE BOER, Anthonius.British journal of clinical pharmacology. 2011, Vol 72, Num 6, pp 909-911, issn 0306-5251, 3 p.Article

Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes MellitusMATTILA, Taina K; DE BOER, Anthonius.Drugs (Basel). 2010, Vol 70, Num 17, pp 2229-2245, issn 0012-6667, 17 p.Article

Comparison of knowledge and accessibility to information sources of HIV/AIDS between blind and sighted populations in NigeriaOTTE, Willem M; VAN DER MAAS, Frank; DE BOER, Anthonius et al.AIDS Care (Print). 2008, Vol 20, Num 9, pp 1093-1097, issn 0954-0121, 5 p.Article

Effect of oral antiplatelet agents on major bleeding in users of coumarinsSCHALEKAMP, Tom; KLUNGEL, Olaf H; SOUVEREIN, Patrick C et al.Thrombosis and haemostasis. 2008, Vol 100, Num 6, pp 1076-1083, issn 0340-6245, 8 p.Article

The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimenVAN WIJK, Boris L. G; KLUNGEL, Olaf H; HEERDINK, Eibert R et al.Journal of hypertension. 2004, Vol 22, Num 9, pp 1831-1837, issn 0263-6352, 7 p.Article

Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision MakingFRANKEN, Margreet; NILSSON, Fredrik; SANDMANN, Frank et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 9, pp 781-797, issn 1170-7690, 17 p.Article

Generic substitution of antihypertensive drugs : Does it affect adherence?VAN WIJK, Boris L. G; KLUNGEL, Olaf H; HEERDINK, Eibert R et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 1, pp 15-20, issn 1060-0280, 6 p.Article

Reducing prescribing of highly anticholinergic antidepressants for elderly people : randomised trial of group versus individual academic detailingVAN EIJK, Martine E. C; AVORN, Jerry; PORSIUS, Arijan J et al.BMJ. British medical journal (International ed.). 2001, Vol 322, Num 7287, pp 654-657, issn 0959-8146Article

Pharmacogenomics of coumarin anticoagulants : Are we underestimating the role of CYP2C9?SCHALEKAMP, Tom; MAITLAND -VAN DER ZEE, Anke-Hilse; DE BOER, Anthonius et al.Thrombosis and haemostasis. 2008, Vol 100, Num 2, pp 175-176, issn 0340-6245, 2 p.Article

Rate and determinants of 10-year persistence with antihypertensive drugsVAN WIJK, Boris L. G; KLUNGEL, Olaf H; HEERDINK, Eibert R et al.Journal of hypertension. 2005, Vol 23, Num 11, pp 2101-2107, issn 0263-6352, 7 p.Article

Drug therapy for prevention of recurrent myocardial infarctionVAN DER ELST, Menno E; BUURMA, Henk; BOUVY, Marcel L et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 10, pp 1465-1477, issn 1060-0280, 13 p.Article

Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and CoumarinsSCHALEKAMP, Tom; KLUNGEL, Olaf H; SOUVEREIN, Patrick C et al.Archives of internal medicine (1960). 2008, Vol 168, Num 2, pp 180-185, issn 0003-9926, 6 p.Article

Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculationVAN WIJK, Boris L. G; KLUNGEL, Olaf H; HEERDINK, Eibert R et al.Journal of clinical epidemiology. 2006, Vol 59, Num 1, pp 11-17, issn 0895-4356, 7 p.Article

Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication : A systematic reviewVAN WIJK, Boris L. G; KLUNGEL, Olaf H; HEERDINK, Eibert R et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 2, pp 319-328, issn 1060-0280, 10 p.Article

Effect of drug combinations on admission for recurrent myocardial infarctionVAN DER ELST, Menno E; BOUVY, Marcel L; DE BLAEY, Cornelis J et al.Heart (London 1996). 2007, Vol 93, Num 10, pp 1226-1230, issn 1355-6037, 5 p.Article

Recent trends in (under)treatment of hypercholesterolaemia in the NetherlandsMANTEL-TEEUWISSE, Aukje K; VERSCHUREN, W. M; KLUNGEL, Olaf H et al.British journal of clinical pharmacology. 2004, Vol 58, Num 3, pp 310-316, issn 0306-5251, 7 p.Article

Instrumental variables : Application and limitationsMARTENS, Edwin P; PESTMAN, Wiebe R; DE BOER, Anthonius et al.Epidemiology (Cambridge, Mass.). 2006, Vol 17, Num 3, pp 260-267, issn 1044-3983, 8 p.Article

Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in the Netherlands : A retrospective analysisVAN DER ELST, Menno E; BOUVY, Marcel L; DE BLAEY, Cornelis J et al.Clinical therapeutics. 2005, Vol 27, Num 11, pp 1806-1814, issn 0149-2918, 9 p.Article

Oral antithrombotic use among myocardial infarction patientsVAN DER ELST, Menno E; CISNEROS-GONZALEZ, Nelly; DE BLAEY, Cornelis J et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 1, pp 143-146, issn 1060-0280, 4 p.Article

Systematic differences in treatment effect estimates between propensity score methods and logistic regressionMARTENS, Edwin P; PESTMAN, Wiebe R; DE BOER, Anthonius et al.International journal of epidemiology. 2008, Vol 37, Num 5, pp 1142-1147, issn 0300-5771, 6 p.Article

Comparison of different methods to estimate prevalence of drug use by using pharmacy recordsMANTEL-TEEUWISSE, Aukje K; KLUNGEL, Olaf H; VERSCHUREN, W. M et al.Journal of clinical epidemiology. 2001, Vol 54, Num 11, pp 1181-1186, issn 0895-4356Article

Improving pharmacotherapy after myocardial infarction by group academic detailing using feedback data on a patient levelVAN DER ELST, Menno E; BOUVY, Marcel L; DE BLAEY, Cornelis J et al.Pharmacotherapy. 2006, Vol 26, Num 2, pp 254-259, issn 0277-0008, 6 p.Article

Variation in Renin―Angiotensin System and Salt-Sensitivity Genes and the Risk of Diabetes Mellitus Associated With the Use of Thiazide DiureticsBOZKURT, Özlem; DE BOER, Anthonius; GROBBEE, Diederik E et al.American journal of hypertension. 2009, Vol 22, Num 5, pp 545-551, issn 0895-7061, 7 p.Article

Five-year fracture risk estimation in patients with Parkinson's diseasePOUWELS, Sander; BAZELIER, Marloes T; DE BOER, Anthonius et al.Bone (New York, NY). 2013, Vol 56, Num 2, pp 266-270, issn 8756-3282, 5 p.Article

Acenocoumarol stabilization is delayed in CYP2C9*3 carriersSCHALEKAMP, Tom; VAN GEEST-DAALDEROP, Johanna H. H; DE VRIES-GOLDSCHMEDING, Hanneke et al.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 5, pp 394-402, issn 0009-9236, 9 p.Article